Kamran Hosseini | Biochemistry | Best Researcher Award

Best Researcher Award

Kamran Hosseini
Affiliation Shiraz University of Medical Sciences
Country Iran
Scopus ID 57226155096
Documents 32
Citations 638
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0003-1189-7143

Kamran Hosseini
Shiraz University of Medical Sciences, Iran

The Best Researcher Award recognizes distinguished scholars whose sustained scientific achievements, publication record, research quality, and academic influence demonstrate excellence within their respective disciplines. Kamran Hosseini has established an active research profile in biochemistry, genetics, molecular biology, neuroscience, and clinical medicine through peer-reviewed publications addressing neurological disorders, molecular signaling pathways, spinal surgery, and translational biomedical research.[1] His scholarly output, citation impact, and international visibility provide evidence of continued contributions to medical science and interdisciplinary biomedical research.[2]

Abstract

Kamran Hosseini has contributed to contemporary biomedical research through investigations spanning molecular biology, neurology, neurosurgery, gene therapy, spinal disorders, and translational medicine. His publication portfolio demonstrates interdisciplinary collaboration while integrating laboratory discoveries with clinical applications. Current research includes viral vector-mediated therapeutic strategies, spinal surgery outcomes, neurological disease mechanisms, and complex neurosurgical case management.[3] Such work reflects sustained engagement with evidence-based medicine and translational biomedical science.

Keywords

Best Researcher Award, Kamran Hosseini, Neuroscience, Molecular Biology, Gene Therapy, AAV Vectors, Biochemistry, Genetics, Neurosurgery, Clinical Research, Biomedical Science, Translational Medicine, Shiraz University of Medical Sciences.

Introduction

Recognition through a Best Researcher Award is commonly based upon sustained scholarly productivity, measurable research impact, publication quality, interdisciplinary collaboration, and contributions to scientific advancement. Researchers working across molecular biology and clinical medicine play an important role in translating laboratory discoveries into practical healthcare improvements.[1] Kamran Hosseini’s research activities illustrate this translational approach by integrating basic biological science with clinical neurosurgical investigations.

Research Profile

  • Affiliation: Shiraz University of Medical Sciences
  • Primary discipline: Biochemistry, Genetics and Molecular Biology
  • Scopus documents: 32
  • Total citations: 638
  • Scopus h-index: 10
  • Research interests include neuroscience, molecular signaling pathways, neurosurgery, spinal disorders, translational medicine, and gene therapy.

Research Contributions

The research portfolio demonstrates contributions across molecular neuroscience, neurological disorders, spinal surgery, and clinical case studies. Recent investigations evaluate adeno-associated virus (AAV) vectors for therapeutic modulation of cellular signaling pathways, assess perioperative interventions to reduce blood loss during spinal fusion procedures, and document rare neurosurgical cases that contribute to evidence-based clinical decision making.[3] These publications illustrate interdisciplinary collaboration between molecular biology and clinical neuroscience while supporting translational healthcare research.

Publications

  • AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders, Cell Biochemistry and Function (2026). DOI: 10.1002/cbf.70270.
  • Prophylactic effects of tranexamic acid in spinal fusion, Egyptian Journal of Neurosurgery (2026). DOI: 10.1186/s41984-026-00560-8.
  • Giant Lumbosacral Meningioma Without Dural Attachment in an Adolescent, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578462.
  • Management of Intrathoracic Huge Meningocele in Neurofibromatosis Type-1, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578419.
  • Kümmell’s Disease in Benign Vertebral Compression Fractures, Clinical Neurology and Neurosurgery (2026). DOI: 10.1016/j.clineuro.2025.109262.

Research Impact

Available bibliometric indicators demonstrate an established publication record comprising 32 indexed documents, 638 citations, and an h-index of 10. These metrics indicate continued scholarly engagement and measurable scientific visibility within biomedical research.[1] The combination of molecular biology, neuroscience, and clinical investigations contributes to interdisciplinary knowledge relevant to both research laboratories and healthcare practice.

Award Suitability

Based on the available academic profile, publication activity, citation performance, interdisciplinary research scope, and contributions to peer-reviewed biomedical literature, Kamran Hosseini demonstrates characteristics commonly evaluated for academic recognition programs such as the Best Researcher Award. His research integrates molecular science with clinical application while contributing to neurological disease research, spinal surgery, and translational medicine through internationally published scientific work.[2]

Conclusion

Kamran Hosseini’s scholarly record reflects sustained participation in biomedical research characterized by interdisciplinary collaboration, clinically relevant investigations, and measurable academic impact. His publication portfolio, citation metrics, and recent contributions to neuroscience and molecular biology illustrate a research trajectory aligned with internationally recognized standards of scientific excellence and make his profile appropriate for consideration within academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Kamran Hosseini, Author ID 57226155096. Scopus.
    https://www.scopus.com/pages/authors/57226155096
  2. ORCID. (n.d.). Kamran Hosseini ORCID Record.
    https://orcid.org/0000-0003-1189-7143
  3. Hosseini K. et al. (2026). AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies. Cell Biochemistry and Function. DOI: https://doi.org/10.1002/cbf.70270
  4. Hosseini K. et al. (2026). Prophylactic effects of tranexamic acid in spinal fusion. Egyptian Journal of Neurosurgery. https://doi.org/10.1186/s41984-026-00560-8
  5. Recent peer-reviewed publications in International Medical Case Reports Journal and Clinical Neurology and Neurosurgery (2026). https://doi.org/10.2147/IMCRJ.S578462

Che-Fan Huang | Proteomics | Best Researcher Award

Dr. Che-Fan Huang | Proteomics | Best Researcher Award

Dr. Che-Fan Huang | Proteomics | Postdoctoral Scholar at Northwestern University | United States

Dr. Che-Fan Huang is a distinguished scientist whose work at the intersection of proteomics, mass spectrometry, and molecular biochemistry has positioned him as a rising leader in top-down proteomic research and proteoform analysis. Dr. Che-Fan Huang completed his advanced academic training in biochemistry and proteomics, developing a strong foundation in analytical chemistry, biomolecular characterization, and protein structure–function relationships. His professional experience spans high-impact research collaborations across internationally recognized laboratories, where he has contributed to groundbreaking advancements in engineered nanoparticles, proteoform profiling, phosphatase signaling, and clinical proteomics. Dr. Che-Fan Huang’s research interests focus on deep proteome mapping, proteoform-centric quantification, enzyme specificity profiling, structural proteomics, and the integration of mass spectrometry with emerging bioanalytical technologies to address complex biomedical questions. His research skills include proteoform characterization, top-down and bottom-up mass spectrometry, SAMDI-MS, peptide array analysis, enzymatic specificity profiling, nanoparticle-assisted proteomics, and high-resolution protein quantification methods. Dr. Che-Fan Huang has been recognized through various honors, including citations in prestigious journals such as Angewandte Chemie, ACS Combinatorial Science, Analytical Chemistry, Journal of Proteome Research, and Molecular & Cellular Proteomics, reflecting the broad impact of his contributions on chemical biology and translational proteomics. Through his sustained commitment to innovation, Dr. Che-Fan Huang continues to advance next-generation proteomic technologies, contributing significant insights into disease mechanisms, protein structural dynamics, and biomarker discovery. In conclusion, Dr. Che-Fan Huang stands as an influential figure whose scientific rigor, technical expertise, and forward-thinking research continue to elevate the field of proteomics, solidifying his reputation as a leading scholar and innovator in modern biochemical analysis.

Profile: Google Scholar

Featured Publications

  1. Huang, C.-F., Wood, S. E., Sinsinbar, G., Gudlur, S., Nallani, M., Liedberg, B., … (2017). A bottom-up proteomic approach to identify substrate specificity of outer-membrane protease OmpT. Angewandte Chemie International Edition, 56(52), 16531–16535. (Cited by: 48)

  2. Szymczak, L. C., Huang, C.-F., Berns, E. J., & Mrksich, M. (2018). Combining SAMDI mass spectrometry and peptide arrays to profile phosphatase activities. Methods in Enzymology, 607, 389–403. (Cited by: 27)

  3. Huang, C.-F., & Mrksich, M. (2019). Profiling protein tyrosine phosphatase specificity with self-assembled monolayers for matrix-assisted laser desorption/ionization mass spectrometry and peptide arrays. ACS Combinatorial Science, 21(11), 760–769. (Cited by: 19)

  4. Huang, C.-F., Hollas, M. A., Sanchez, A., Bhattacharya, M., Ho, G., Sundaresan, A., … (2024). Deep profiling of plasma proteoforms with engineered nanoparticles for top-down proteomics. Journal of Proteome Research, 23(10), 4694–4703. (Cited by: 16)

  5. Huang, C.-F., Kline, J. T., Negrão, F., Robey, M. T., Toby, T. K., Durbin, K. R., … (2024). Targeted quantification of proteoforms in complex samples by proteoform reaction monitoring. Analytical Chemistry, 96(8), 3578–3586. (Cited by: 15)

  6. Forte, E., Sanders, J. M., Pla, I., Kanchustambham, V. L., Hollas, M. A. R., Huang, C.-F., … (2024). Top-down proteomics identifies plasma proteoform signatures of liver cirrhosis progression. Molecular & Cellular Proteomics, 23(12), 100876. (Cited by: 7)

  7. Xu, T., Su, T., Soye, B. J. D., Kandi, S., Huang, C.-F., Wilkins, J. T., Castellani, R. J., … (2025). The proteoform landscape of Tau from the human brain. Journal of Proteome Research, 24(6), 2916–2925. (Cited by: 5)